Sarcoidosis: Changed phenotype and worsening of the course by overtime

Metin Basaranoglu (Istanbul, Turkey), Sevtap Sipahi, Metin Basaranoglu, Mert Bal, Tuncer Karayel

Source: International Congress 2015 – Acute and chronic lung diseases: good clinical practice
Session: Acute and chronic lung diseases: good clinical practice
Session type: Thematic Poster Session
Number: 3692

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Metin Basaranoglu (Istanbul, Turkey), Sevtap Sipahi, Metin Basaranoglu, Mert Bal, Tuncer Karayel. Sarcoidosis: Changed phenotype and worsening of the course by overtime. Eur Respir J 2015; 46: Suppl. 59, 3692

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Childhood pulmonary sarcoidosis
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013

Does the HLA-DRB1-genotype influence the course of disease in Danish sarcoidosis patients?
Source: Annual Congress 2013 –Sarcoidosis
Year: 2013


Pulmonary manifestations in adult patients with chronic granulomatous disease
Source: Annual Congress 2013 –Clinical management of orphan lung diseases
Year: 2013



Exacerbations of bronchiectasis: Etiology and outcome
Source: International Congress 2016 – Orphan diseases II
Year: 2016


Chronic granulomatous disease diagnosed in adulthood- Report of 2 Cases
Source: International Congress 2015 – Immune mechanisms in the human lung
Year: 2015

Are there any predictors of MTX response in progressive pulmonary sarcoidosis?
Source: International Congress 2015 – Acute and chronic lung diseases: good clinical practice
Year: 2015

Relation of hemogram parameters with asthma
Source: International Congress 2015 – Asthma and lung immunology
Year: 2015


Childhood diffuse parenchymal lung diseases: Diagnosis, treatment and outcome
Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Year: 2013

Sarcoidosis and chronic beryllium disease: Differences in genotype and phenotype?
Source: Research Seminar 2004 - Genotyping and Phenotyping of Diffuse Parenchymal Lung Diseases
Year: 2004


Cognitive failure in sarcoidosis
Source: International Congress 2014 – Sarcoidosis
Year: 2014


Atypical variants of clinical course of sarcoidosis
Source: International Congress 2014 – ILDs 6
Year: 2014

Treating peripheral eosinophilia in asthma: Simple and effective
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013

The metabolic syndrome in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014


Methotrexate (MTX) as a single agent for treating chronic, progressive sarcoidosis
Source: International Congress 2014 – Sarcoidosis
Year: 2014

Necrosis as a predictor of infection in granulomatous lung disease
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013

The relationship between COPD and periodontitis
Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD
Year: 2015

Bronchiectasis in the children
Source: Annual Congress 2013 –Research questions on how viruses affect the respiratory system
Year: 2013

Chronic hypersensitivity pneumonitis: Is the interstitial pneumonias disease behavior classification suitable for outcome stratification?
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015

Inorganic exposome in pediatric sarcoidosis: The PEDIASARC study
Source: International Congress 2015 – Sarcoidosis: clinical
Year: 2015


Sarcoidosis related to interferon and ribavirin treatment of hepatitis C – Analysis of four cases
Source: International Congress 2014 – Sarcoidosis
Year: 2014